Src family kinase inhibitor PP2 accelerates differentiation in human intestinal epithelial cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 4, 2013, Pages 1195-1200

  Seltana, Amira ^a   Guezguez, Amel ^a   Lepage, Manon ^a   Basora, Nuria ^a   Beaulieu, Jean François ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Caco 2 cells; Cdx2; Cell differentiation; H3K27me3; HNF1 ; Human; Intestine; Src kinase

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; PHLORIZIN; PROTEIN TYROSINE KINASE; SUCRASE ISOMALTASE; TRANSCRIPTION FACTOR CDX2; UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CELL POLARITY; EPIGENETIC REPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CACO-2 CELLS; CELL DIFFERENTIATION; HUMANS; INTESTINAL MUCOSA; INTESTINES; PYRIMIDINES; SRC-FAMILY KINASES; TRANSCRIPTION FACTORS;

EID: 84872847970     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.085     Document Type: Article

References (43)

1. Parsons S.J., Parsons J.T. Src family kinases, key regulators of signal transduction. Oncogene 2004, 23:7906-7909.
2. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 2004, 4:470-480.
3. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13:513-609.
4. Roskoski R. Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 2004, 324:1155-1164.
5. Bouchard V., Demers M.J., Thibodeau S., Laquerre V., Fujita N., Tsuruo T., Beaulieu J.F., Gauthier R., Vezina A., Villeneuve L., Vachon P.H. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J. Cell. Physiol. 2007, 212:717-728.
6. Irby R.B., Yeatman T.J. Role of Src expression and activation in human cancer. Oncogene 2000, 19:5636-5642.
7. Wheeler D.L., Iida M., Dunn E.F. The role of Src in solid tumors. Oncologist 2009, 14:667-678.
8. Criscuoli M.L., Nguyen M., Eliceiri B.P. Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood 2005, 105:1508-1514.
9. Trevino J.G., Summy J.M., Lesslie D.P., Parikh N.U., Hong D.S., Lee F.Y., Donato N.J., Abbruzzese J.L., Baker C.H., Gallick G.E. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am. J. Pathol. 2006, 168:962-972.
10. Metcalf C.A., van Schravendijk M.R., Dalgarno D.C., Sawyer T.K. Targeting protein kinases for bone disease: discovery and development of Src inhibitors. Curr. Pharm. Des. 2002, 8:2049-2075.
11. GuezGuez A., Prod'homme V., Mouska X., Baudot A., Blin-Wakkach C., Rottapel R., Deckert M. 3BP2 Adapter protein is required for receptor activator of NFkappaB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells. J. Biol. Chem. 2010, 285:20952-20963.
12. Zamoyska R., Basson A., Filby A., Legname G., Lovatt M., Seddon B. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol. Rev. 2003, 191:107-118.
13. Thompson O., Kleino I., Crimaldi L., Gimona M., Saksela K., Winder S.J. Dystroglycan, Tks5 and Src mediated assembly of podosomes in myoblasts. PLoS ONE 2008, 3:e3638.
14. Bursell L., Woods A., James C.G., Pala D., Leask A., Beier F. Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res. Ther. 2007, 9:R105.
15. Klener P., Klener P. ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy. Klin Onkol 2010, 23:203-209.
16. Kong L., Deng Z., Shen H., Zhang Y. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Mol. Cell. Biochem. 2011, 348:11-19.
17. Daoud G., Rassart E., Masse A., Lafond J. Src family kinases play multiple roles in differentiation of trophoblasts from human term placenta. J. Physiol. 2006, 571:537-553.
18. Daoud G., Le bellego F., Lafond J. PP2 regulates human trophoblast cells differentiation by activating p38 and ERK1/2 and inhibiting FAK activation. Placenta 2008, 29:862-870.
19. Lee Y.C., Huang C.F., Murshed M., Chu K., Araujo J.C., Ye X., deCrombrugghe B., Yu-Lee L.Y., Gallick G.E., Lin S.H. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Oncogene 2010, 29:3196-3207.
20. Bjerknes M., Cheng H. Gastrointestinal stem cells. II. Intestinal stem cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G381-G387.
21. Scoville D.H., Sato T., He X.C., Li L. Current view: intestinal stem cells and signaling. Gastroenterology 2008, 134:849-864.
22. Babyatsky M.W., Podolsky D.K. Growth and development of the gastrointestinal tract. Textbook of Gastroenterology 1999, 547-584. J.B. Lippincott, Philadelphia. T. Yamada (Ed.).
23. Beaulieu J.F., Quaroni A. Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochem. J. 1991, 280(Pt 3):599-608.
24. Beaulieu J.F., Weiser M.M., Herrera L., Quaroni A. Detection and characterization of sucrase-isomaltase in adult human colon and in colonic polyps. Gastroenterology 1990, 98:1467-1477.
25. Vachon P.H., Beaulieu J.F. Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology 1992, 103:414-423.
26. Beaulieu J.F., Nichols B., Quaroni A. Posttranslational regulation of sucrase-isomaltase expression in intestinal crypt and villus cells. J. Biol. Chem. 1989, 264:20000-20011.
27. Seltana A., Basora N., Beaulieu J.F. Caco-2 cells as an experimental model to study cell-matrix interactions and wound healing on intestinal villus cells. Caco-2 Cells and Their Uses 2012, 77-88. Nova Sciences Publishers. M.A. Schulz (Ed.).
28. Benoit Y.D., Lepage M.B., Khalfaoui T., Tremblay E., Basora N., Carrier J.C., Gudas L.J., Beaulieu J.F. Polycomb repressive complex 2 impedes intestinal cell terminal differentiation. J. Cell Sci. 2012, 125:3454-3463.
29. Escaffit F., Pare F., Gauthier R., Rivard N., Boudreau F., Beaulieu J.F. Cdx2 modulates proliferation in normal human intestinal epithelial crypt cells. Biochem. Biophys. Res. Commun. 2006, 342:66-72.
30. Benoit Y.D., Pare F., Francoeur C., Jean D., Tremblay E., Boudreau F., Escaffit F., Beaulieu J.F. Cooperation between HNF-1alpha, Cdx2, and GATA-4 in initiating an enterocytic differentiation program in a normal human intestinal epithelial progenitor cell line. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G504-G517.
31. Dydensborg A.B., Herring E., Auclair J., Tremblay E., Beaulieu J.F. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1067-G1074.
32. Escaffit F., Boudreau F., Beaulieu J.F. Differential expression of claudin-2 along the human intestine: Implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J. Cell. Physiol. 2005, 203:15-26.
33. Vachon P.H., Perreault N., Magny P., Beaulieu J.F. Uncoordinated, transient mosaic patterns of intestinal hydrolase expression in differentiating human enterocytes. J. Cell. Physiol. 1996, 166:198-207.
34. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim. Biophys. Acta 2008, 1784:56-65.
35. Serrels A., Canel M., Brunton V.G., Frame M.C. Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging. Cell Adh. Migr. 2011, 5:360-365.
36. McLachlan R.W., Yap A.S. Protein tyrosine phosphatase activity is necessary for E-cadherin-activated Src signaling. Cytoskeleton (Hoboken) 2011, 68:32-43.
37. Laprise P., Chailler P., Houde M., Beaulieu J.F., Boucher M.J., Rivard N. Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation. J. Biol. Chem. 2002, 277:8226-8234.
38. Houde M., Laprise P., Jean D., Blais M., Asselin C., Rivard N. Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2. J. Biol. Chem. 2001, 276:21885-21894.
39. Sun B.K., Kim J.H., Nguyen H.N., Oh S., Kim S.Y., Choi S., Choi H.J., Lee Y.J., Song J.J. MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation. Oncol. Rep. 2011, 25:537-544.
40. Takaishi K., Sasaki T., Kotani H., Nishioka H., Takai Y. Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J. Cell Biol. 1997, 139:1047-1059.
41. Hebbard L., Cecena G., Golas J., Sawada J., Ellies L.G., Charbono A., Williams R., Jimenez R.E., Wankell M., Arndt K.T., DeJoy S.Q., Rollins R.A., Diesl V., Follettie M., Chen L., Rosfjord E., Cardiff R.D., Komatsu M., Boschelli F., Oshima R.G. Control of mammary tumor differentiation by SKI-606 (bosutinib). Oncogene 2011, 30:301-312.
42. Bosse T., Fialkovich J.J., Piaseckyj C.M., Beuling E., Broekman H., Grand R.J., Montgomery R.K., Krasinski S.D. Gata4 and Hnf1alpha are partially required for the expression of specific intestinal genes during development. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1302-G1314.
43. Boudreau F., Rings E.H., van Wering H.M., Kim R.K., Swain G.P., Krasinski S.D., Moffett J., Grand R.J., Suh E.R., Traber P.G. Hepatocyte nuclear factor-1 alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J. Biol. Chem. 2002, 277:31909-31917.